Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VLO vs MRNA✓SelectedUSD · MRNAVLO vs MRNA performance historyLatest closeAs of-1.52%11/19
Stock and ETF performance explorer

VLO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+502.1%
MRNA return
+806.0%
Excess return
-303.9%
Maximum drawdown
-67.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.5%+1.3%-2.8%-1.5%
7D-9.7%-13.8%+4.1%-9.6%
30D-21.9%-17.7%-4.3%-21.8%
3M-2.3%+14.3%-16.6%-2.4%
6M+30.0%+336.0%-306.0%+26.7%
YTD+111.0%+575.9%-464.9%+102.8%
1Y+91.7%+724.4%-632.7%+83.2%
3Y+193.8%+160.8%+33.0%+184.0%
5Y+464.9%-24.4%+489.3%+449.5%
All+502.1%+806.0%-303.9%+401.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling